Tumor Markers
Tumor markers are integral part of modern cancer management. They are primarily used for monitoring but also for diagnostic and prognostic purposes in combination with clinical and other paraclinical parameters.
AFP
Quantitative determination of Alpha-Fetoprotein
Format | REF | Size | Remark | Sample |
---|---|---|---|---|
Antigen test | 52010 | 96 tests | WHO calibration | Serum |
CA 125 Ag
Quantitative determination of cancer antigen 125 (CA 125 Ag)
Format | REF | Size | Sample |
---|---|---|---|
Antigen test | 52050 | 96 tests | Serum |
CA 15-3 Ag
Quantitative determination of cancer antigen 15-3 (CA 15-3 Ag)
Format | REF | Size | Sample |
---|---|---|---|
Antigen test | 52080 | 96 tests | Serum |
CA 19-9 Ag
Quantitative determination of cancer antigen 19-9 (CA 19-9 Ag)
Format | REF | Size | Sample |
---|---|---|---|
Antigen test | 52060 | 96 tests | Serum |
CEA
Quantitative determination of carcinoembryonic antigen
Format | REF | Size | Remark | Sample |
---|---|---|---|---|
Antigen test | 52020 | 96 tests | WHO calibration | Serum |
PSA
Quantitative determination of total prostate specific antigen
Format | REF | Size | Remark | Sample |
---|---|---|---|---|
Antigen test | 52030 | 96 tests | WHO calibration | Serum |
fPSA
Quantitative determination of free prostate specific antigen
Format | REF | Size | Remark | Sample |
---|---|---|---|---|
Antigen test | 52035 | 96 tests | WHO calibration | Serum |
